Whether you're a clinician, researcher, hospital administrator, investor, or patient advocate — we want to hear from you.
Our labs and clinical operations are based within the University Health Network at Toronto University Hospital — one of the world's top ten research hospitals.
Located inside Toronto University Hospital Innovation Wing — accessible via the College Street main entrance, Level 4 east corridor.
We respond to all enquiries within one business day.
Reach the right people directly — from clinical implementation to investor relations.
Technical specifications, integration queries, and R&D partnerships.
science@advancemedpro.caHospital deployments, clinical trials, regulatory and compliance queries.
clinical@advancemedpro.caAcademic collaborations, grant co-applications, and data sharing agreements.
research@advancemedpro.caLicensing, distribution partnerships, and commercial agreements.
biz@advancemedpro.caCurrent openings in photonics, AI, clinical research, and engineering.
careers@advancemedpro.caThe scientists, clinicians, and technologists behind Advance Med Pro's breakthroughs.
PhD Medical Biophysics, University of Toronto. Former senior researcher at National Research Council Canada's Photonics Research Centre. Inventor of QuantaFlux™ and ChromaDerm™.
Director of Neurosurgery, UHN Toronto. Professor at U of T Faculty of Medicine. Lead clinical architect of NeuroPulse™ NPOM. 300+ peer-reviewed publications.
MSc Photonics (Imperial College), PhD Quantum Optics (MIT). Lead engineer behind BioLumin™ BLRI sensor array design and the QuantaCore AI inference chip.
Former Clinical Trials Lead, Princess Margaret Cancer Centre. Oversees all 12 active trials and international research partnerships. Specialist in oncology and emergency medicine biomarkers.
MBA Rotman School of Management. Previously VP Operations at Profound Medical. Led Health Canada and FDA Class II device registration for PhoTissue™ and ChromaDerm™ platforms.
Former research scientist at Google DeepMind Health. Architect of ChromaNet v3 — the deep learning model powering ChromaDerm™'s 47-biomarker panel. Expert in spectral signal processing.
We're a team of 68 scientists, engineers, and clinicians on a mission to eliminate invasive diagnostics. If that mission excites you, we want you.
Design and optimise multi-wavelength quantum dot emitter arrays for the next generation of QuantaFlux sensors. 5+ years photonics hardware experience required.
Extend ChromaNet v3 to new biomarker targets and new sensor modalities. Strong background in signal processing and deep learning for tabular/spectral data required.
Support BLRI clinical trials at Princess Margaret Cancer Centre. Experience in oncology clinical trials coordination and GCP certification required.
Lead regulatory submissions for NeuroPulse™ NPOM Health Canada Class III upgrade and US FDA 510(k) pathway. RAC certification preferred.
2-year postdoctoral fellowship co-supervised with University of Toronto Dept. of Medical Biophysics. Research focus: extending BLRI to pancreatic and ovarian cancer microenvironments.
Drive adoption of ChromaDerm™ and PhoTissue™ in Ontario and Atlantic Canada hospital networks. 3+ years medical device sales experience required.
Book a live lab demonstration at Toronto University Hospital — see our five breakthrough technologies in action.